CytomX Therapeutics Market Cap 2014-2022 | CTMX
CytomX Therapeutics market cap history and chart from 2014 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. CytomX Therapeutics market cap as of February 03, 2023 is $0.18B.
||Medical - Biomedical and Genetics
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.